Infinitus Presents Human Evidence-Based Research Findings at FFC 2026
GUANGZHOU, China, April 30, 2026 /PRNewswire/ -- Ma Jun, Vice President and Chief Science Innovation Officer of Infinitus (China) Company Ltd., was invited to attend the Functional Food Conference 2026 (FFC 2026), held recently in Hangzhou, Zhejiang Province, where he delivered a keynote presentation. In his remarks, Ma outlined the company's research foundation and ongoing innovation in the...
New study demonstrates up to 73% reduction in genome analysis errors using AI-trained models versus standard approaches
SAN JOSE, Calif., April 29, 2026 /PRNewswire/ -- Complete Genomics, a U.S.-based leader in genomic sequencing technologies, today announced results demonstrating that AI-trained variant calling models can reduce genome analysis errors by up to 73% when applied to DNBSEQ™ sequencing data generated on its advanced massively parallel sequencing platform compared to widely used industry standard pipelines. Accurate genome interpretation...
Navinci launches Omni kit – the next generation of spatial interactomics
UPPSALA, Sweden, April 29, 2026 /PRNewswire/ -- Navinci today announces the launch of Omni, breakthrough fully customized kits designed to transform how scientists study protein function directly in tissue. Omni provides cutting-edge spatial interactomics capabilities, enabling researchers to map protein networks and better understand health, disease progression, and drug mechanisms. Built on Navinci's proprietary in situ proximity ligation assay (isPLA)...
WuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access
Contributing to the United Nations Sustainable Development Goals, driving equitable access to healthcare through technology and innovation Enhancing governance transparency and effectiveness to create long-term value for all stakeholders Empowering employees and fostering shared value with communities Accelerating climate actions and strengthening environmental stewardship Leading Green CRDMO solutions to support global clients' sustainability journeys HONG KONG, April...
Vivacta Bio Closed Series A and Series A+ Financing of Over US$50 Million
Backed by Decheng Capital, Loyal Valley Capital, OrbiMed, and Other Renowned Investors SHANGHAI, April 29, 2026 /PRNewswire/ -- Vivacta Biotechnology (Shanghai) Co., Ltd. ("Vivacta" or "Vivacta Bio"), an innovative biotechnology company focused on revolutionizing in vivo CAR-T therapies, announces the company recently completed Series A and Series A+ financing of over US$...
United Imaging Healthcare Releases 2025 Annual Report and Q1 2026 Results, Delivering Strong Growth with Accelerated Global Expansion
SHANGHAI, April 29, 2026 /PRNewswire/ -- United Imaging Healthcare (688271.SH)，a global innovator in advanced medical imaging technologies and intelligent healthcare solutions, announced its 2025 annual results and Q1 2026 performance, both delivering solid growth. In 2025, the company reported revenue of RMB 13.80 billion, representing a year-on-year increase of 33.98%, and net profit attributable to shareholders of RMB 1.87...
United Imaging Healthcare Releases 2025 ESG Report: Upgraded to MSCI “AA” Rating, Driving Sustainable Development Through Innovation
SHANGHAI, April 29, 2026 /PRNewswire/ -- United Imaging Healthcare (SSE:688271) has released its 2025 Environmental, Social and Governance (ESG) Report, outlining the company's strategic framework, key initiatives, and long-term commitments across sustainability. Over the past year, the company has continued to strengthen its sustainability performance. MSCI upgraded United Imaging Healthcare's ESG rating from "A" to "AA," marking the...
ESG | HitGen Releases 2025 Sustainability Report
CHENGDU, China, April 29, 2026 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) released its 2025 Sustainability Report on April 29, 2026. This report is the second sustainability report of HitGen, aiming to present the Company's philosophies and policies in environmental, social, and governance ("ESG") areas, as well...
LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions
ANDERNACH, Germany, April 29, 2026 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today announced the expansion of its service portfolio to include CDMO services for ophthalmic drug delivery solutions, with manufacturing capacities located in the United States at LTS' Lakewood, New Jersey facility. The new offering focuses initially...
China’s Yangtze River Pharmaceutical Group Expands Global Footprint as Quality Drives Growth
TAIZHOU, China, April 29, 2026 /PRNewswire/ -- In 2025, Yangtze River Pharmaceutical Group (YRPG) made significant progress in both global growth and quality initiatives. The company's international revenue increased more than fourfold year over year, while the number of its global partners more than doubled. Over 100 products were exported to more than 40 countries and regions across...
